2026. ASSESSMENT OF CARDIOVASCULAR AND RENAL OUTCOMES FOLLOWING DAPAGLIFLOZIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE. Asian Journal of Medical Research and Health Sciences. 4, 2 (Jun. 2026), 1398–1403. DOI:https://doi.org/10.65605/a-jmrhs.2026.v04.i02.pp1398-1403.